Please login to the form below

Not currently logged in
Email:
Password:

GlobalCom selects Pegasus PR

Worldwide PR and communications group, GlobalCom PR Network, has appointed Pegasus PR as its exclusive healthcare agency for the UK

GlobalCom PR Network, a worldwide group of full-service independent public relations and marketing communications agencies, has appointed Pegasus PR as its exclusive healthcare agency for the UK.

Healthcare communications specialist, Pegasus, joins 40 other global partners and affiliated agencies across 69 countries to strengthen GlobalCom's international network of over 1,200 PR consultants. The appointment replaces former UK partner Medicom.

Members of the GlobalCom Health Network include specialised PR agencies with an exclusive focus on healthcare and pharmaceutical businesses in main markets such as the US, Germany, Spain and Italy, as well as emerging and smaller markets.

As part of an international network, Pegasus is now able to develop and execute strategic global campaigns on a local level, improving its international offering to both existing and new clients.

Local in-depth expertise of the media landscape allows the agencies to work together to produce on-message, targeted global coverage, while maintaining low overheads and a central billing and reporting point.

Services include public relations, marketing communications, event support, online marketing and market research. All member agencies boast excellent relationships with industry experts, key opinion leaders and media representatives.

Lisa Bradley, MD of Pegasus said: "As a specialist healthcare agency, Pegasus can bring a wealth of UK health expertise and media knowledge to GlobalCom's international clients looking to widen their communications reach. Likewise, this unique model offers our existing and new clients a cost-effective solution to large global campaigns, with the benefits of local knowledge."

With headquarters in Brussels and Belgium, GlobalCom has successfully executed global campaigns for a number of large blue chip brands across the world including GlaxoSmithKline, Bayer, Roche, Merck and Pfizer.

12th April 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...